Key result
AF ablation in HOCM requires further evaluation to establish definitive efficacy and safety.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
AlTurki et al. (2025) studied this question. Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy requires further clinical evaluation to determine its definitive efficacy and safety profile.
Synapse has enriched 10 related papers. Consider them for comparative context: